TNFRSF11A Antikörper (N-Term)
Kurzübersicht für TNFRSF11A Antikörper (N-Term) (ABIN966946)
Target
Alle TNFRSF11A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 29-44, N-Term
-
Immunogen
- A synthetic peptide corresponding to a sequence at the N-terminal of human RANK (29-44 aa), identical to the related mouse and rat sequence.
-
-
-
-
Applikationshinweise
- WB: The detection limit for RANK is approximately 2.5ng/lane under non-reducing and reducing conditions.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Rekonstitution
- 0.2ml of distilled water will yield a concentration of 500µg/ml.
-
Buffer
- Each vial contains 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4
-
Konservierungsmittel
- Thimerosal (Merthiolate), Sodium azide
-
Lagerung
- -20 °C
-
-
-
: "RANK-L and RANK: T cells, bone loss, and mammalian evolution." in: Annual review of immunology, Vol. 20, pp. 795-823, (2002) (PubMed).
: "Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families." in: Endocrine reviews, Vol. 20, Issue 3, pp. 345-57, (1999) (PubMed).
-
-
- TNFRSF11A (Tumor Necrosis Factor Receptor Superfamily, Member 11a, NFKB Activator (TNFRSF11A))
-
Andere Bezeichnung
- RANK
-
Hintergrund
- Receptor Activator of Nuclear Factor B (RANK), also known as TRANCE Receptor, is a type I membrane protein that is expressed on the surface of osteoclasts and is involved in their activation upon ligand binding. RANK is also expressed on dendritic cells and facilitates immune signaling.RANKL (Receptor Activator for Nuclear Factor B Ligand) is found on the surface of stromal cells, osteoblasts, and T cells. By analysis of somatic cell and radiation hybrid panels, Anderson et al. (1997) mapped the RANK gene to 18q22.1.
-
Pathways
- NF-kappaB Signalweg
Target
-